 | • レポートコード：GIR-2104Z14504 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ワクチン受託製造のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ワクチン受託製造の種類別市場規模（充填仕上げ、バルク製品）、用途別市場規模（製薬産業、バイオテクノロジー産業、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ワクチン受託製造の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Diosynth、Emergent BioSolutions、Goodwin Biotechnology、Bavarian Nordic、Soligenix Inc、Catalent Biologics ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：充填仕上げ、バルク製品 ・用途別分析2016年-2026年：製薬産業、バイオテクノロジー産業、その他 ・ワクチン受託製造の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ワクチン受託製造のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ワクチン受託製造のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ワクチン受託製造の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ワクチン受託製造の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Vaccine Contract Manufacturing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Vaccine Contract Manufacturing size is estimated to be USD 2115.8 million in 2025 from USD 1737.6 million in 2019, with a change XX% between 2019 and 2020. The global Vaccine Contract Manufacturing market size is expected to grow at a CAGR of 5.0% for the next five years.
Market segmentation
Vaccine Contract Manufacturing market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Fill-Finish
Bulk Product
Market segment by Application, can be divided into
Pharmaceutical Companies
Biotech Companies
Others
Market segment by players, this report covers
Diosynth
Emergent BioSolutions
Goodwin Biotechnology
Bavarian Nordic
Soligenix Inc
Catalent Biologics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Vaccine Contract Manufacturing
1.2 Classification of Vaccine Contract Manufacturing by Type
1.2.1 Overview: Global Vaccine Contract Manufacturing Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Vaccine Contract Manufacturing Revenue Market Share by Type in 2020
1.2.3 Fill-Finish
1.2.4 Bulk Product
1.3 Global Vaccine Contract Manufacturing Market by Application
1.3.1 Overview: Global Vaccine Contract Manufacturing Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Pharmaceutical Companies
1.3.3 Biotech Companies
1.3.4 Others
1.4 Global Vaccine Contract Manufacturing Market Size & Forecast
1.5 Global Vaccine Contract Manufacturing Market Size and Forecast by Region
1.5.1 Global Vaccine Contract Manufacturing Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Vaccine Contract Manufacturing Market Size by Region, (2016-2021)
1.5.3 North America Vaccine Contract Manufacturing Market Size and Prospect (2016-2026)
1.5.4 Europe Vaccine Contract Manufacturing Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Vaccine Contract Manufacturing Market Size and Prospect (2016-2026)
1.5.6 South America Vaccine Contract Manufacturing Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Vaccine Contract Manufacturing Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Vaccine Contract Manufacturing Market Drivers
1.6.2 Vaccine Contract Manufacturing Market Restraints
1.6.3 Vaccine Contract Manufacturing Trends Analysis
2 Company Profiles
2.1 Diosynth
2.1.1 Diosynth Details
2.1.2 Diosynth Major Business
2.1.3 Diosynth Vaccine Contract Manufacturing Product and Solutions
2.1.4 Diosynth Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Diosynth Recent Developments and Future Plans
2.2 Emergent BioSolutions
2.2.1 Emergent BioSolutions Details
2.2.2 Emergent BioSolutions Major Business
2.2.3 Emergent BioSolutions Vaccine Contract Manufacturing Product and Solutions
2.2.4 Emergent BioSolutions Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Emergent BioSolutions Recent Developments and Future Plans
2.3 Goodwin Biotechnology
2.3.1 Goodwin Biotechnology Details
2.3.2 Goodwin Biotechnology Major Business
2.3.3 Goodwin Biotechnology Vaccine Contract Manufacturing Product and Solutions
2.3.4 Goodwin Biotechnology Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Goodwin Biotechnology Recent Developments and Future Plans
2.4 Bavarian Nordic
2.4.1 Bavarian Nordic Details
2.4.2 Bavarian Nordic Major Business
2.4.3 Bavarian Nordic Vaccine Contract Manufacturing Product and Solutions
2.4.4 Bavarian Nordic Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Bavarian Nordic Recent Developments and Future Plans
2.5 Soligenix Inc
2.5.1 Soligenix Inc Details
2.5.2 Soligenix Inc Major Business
2.5.3 Soligenix Inc Vaccine Contract Manufacturing Product and Solutions
2.5.4 Soligenix Inc Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Soligenix Inc Recent Developments and Future Plans
2.6 Catalent Biologics
2.6.1 Catalent Biologics Details
2.6.2 Catalent Biologics Major Business
2.6.3 Catalent Biologics Vaccine Contract Manufacturing Product and Solutions
2.6.4 Catalent Biologics Vaccine Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Catalent Biologics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Vaccine Contract Manufacturing Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Vaccine Contract Manufacturing Players Market Share
3.2.2 Top 10 Vaccine Contract Manufacturing Players Market Share
3.2.3 Market Competition Trend
3.3 Vaccine Contract Manufacturing Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Vaccine Contract Manufacturing Revenue and Market Share by Type (2016-2021)
4.2 Global Vaccine Contract Manufacturing Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Vaccine Contract Manufacturing Revenue Market Share by Application (2016-2021)
5.2 Vaccine Contract Manufacturing Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Vaccine Contract Manufacturing Revenue by Type (2016-2026)
6.2 North America Vaccine Contract Manufacturing Revenue by Application (2016-2026)
6.3 North America Vaccine Contract Manufacturing Market Size by Country
6.3.1 North America Vaccine Contract Manufacturing Revenue by Country (2016-2026)
6.3.2 United States Vaccine Contract Manufacturing Market Size and Forecast (2016-2026)
6.3.3 Canada Vaccine Contract Manufacturing Market Size and Forecast (2016-2026)
6.3.4 Mexico Vaccine Contract Manufacturing Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Vaccine Contract Manufacturing Revenue by Type (2016-2026)
7.2 Europe Vaccine Contract Manufacturing Revenue by Application (2016-2026)
7.3 Europe Vaccine Contract Manufacturing Market Size by Country
7.3.1 Europe Vaccine Contract Manufacturing Revenue by Country (2016-2026)
7.3.2 Germany Vaccine Contract Manufacturing Market Size and Forecast (2016-2026)
7.3.3 France Vaccine Contract Manufacturing Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Vaccine Contract Manufacturing Market Size and Forecast (2016-2026)
7.3.5 Russia Vaccine Contract Manufacturing Market Size and Forecast (2016-2026)
7.3.6 Italy Vaccine Contract Manufacturing Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Vaccine Contract Manufacturing Revenue by Type (2016-2026)
8.2 Asia-Pacific Vaccine Contract Manufacturing Revenue by Application (2016-2026)
8.3 Asia-Pacific Vaccine Contract Manufacturing Market Size by Region
8.3.1 Asia-Pacific Vaccine Contract Manufacturing Revenue by Region (2016-2026)
8.3.2 China Vaccine Contract Manufacturing Market Size and Forecast (2016-2026)
8.3.3 Japan Vaccine Contract Manufacturing Market Size and Forecast (2016-2026)
8.3.4 South Korea Vaccine Contract Manufacturing Market Size and Forecast (2016-2026)
8.3.5 India Vaccine Contract Manufacturing Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Vaccine Contract Manufacturing Market Size and Forecast (2016-2026)
8.3.7 Australia Vaccine Contract Manufacturing Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Vaccine Contract Manufacturing Revenue by Type (2016-2026)
9.2 South America Vaccine Contract Manufacturing Revenue by Application (2016-2026)
9.3 South America Vaccine Contract Manufacturing Market Size by Country
9.3.1 South America Vaccine Contract Manufacturing Revenue by Country (2016-2026)
9.3.2 Brazil Vaccine Contract Manufacturing Market Size and Forecast (2016-2026)
9.3.3 Argentina Vaccine Contract Manufacturing Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Vaccine Contract Manufacturing Revenue by Type (2016-2026)
10.2 Middle East & Africa Vaccine Contract Manufacturing Revenue by Application (2016-2026)
10.3 Middle East & Africa Vaccine Contract Manufacturing Market Size by Country
10.3.1 Middle East & Africa Vaccine Contract Manufacturing Revenue by Country (2016-2026)
10.3.2 Turkey Vaccine Contract Manufacturing Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Vaccine Contract Manufacturing Market Size and Forecast (2016-2026)
10.3.4 UAE Vaccine Contract Manufacturing Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Vaccine Contract Manufacturing Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Vaccine Contract Manufacturing Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Vaccine Contract Manufacturing Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Vaccine Contract Manufacturing Revenue (USD Million) by Region (2016-2021)
Table 5. Global Vaccine Contract Manufacturing Revenue Market Share by Region (2021-2026)
Table 6. Diosynth Corporate Information, Head Office, and Major Competitors
Table 7. Diosynth Major Business
Table 8. Diosynth Vaccine Contract Manufacturing Product and Solutions
Table 9. Diosynth Vaccine Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Emergent BioSolutions Corporate Information, Head Office, and Major Competitors
Table 11. Emergent BioSolutions Major Business
Table 12. Emergent BioSolutions Vaccine Contract Manufacturing Product and Solutions
Table 13. Emergent BioSolutions Vaccine Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Goodwin Biotechnology Corporate Information, Head Office, and Major Competitors
Table 15. Goodwin Biotechnology Major Business
Table 16. Goodwin Biotechnology Vaccine Contract Manufacturing Product and Solutions
Table 17. Goodwin Biotechnology Vaccine Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Bavarian Nordic Corporate Information, Head Office, and Major Competitors
Table 19. Bavarian Nordic Major Business
Table 20. Bavarian Nordic Vaccine Contract Manufacturing Product and Solutions
Table 21. Bavarian Nordic Vaccine Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Soligenix Inc Corporate Information, Head Office, and Major Competitors
Table 23. Soligenix Inc Major Business
Table 24. Soligenix Inc Vaccine Contract Manufacturing Product and Solutions
Table 25. Soligenix Inc Vaccine Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Catalent Biologics Corporate Information, Head Office, and Major Competitors
Table 27. Catalent Biologics Major Business
Table 28. Catalent Biologics Vaccine Contract Manufacturing Product and Solutions
Table 29. Catalent Biologics Vaccine Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Global Vaccine Contract Manufacturing Revenue (USD Million) by Players (2019-2021)
Table 31. Global Vaccine Contract Manufacturing Revenue Share by Players (2019-2021)
Table 32. Breakdown of Vaccine Contract Manufacturing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 33. Vaccine Contract Manufacturing Players Head Office, Products and Services Provided
Table 34. Vaccine Contract Manufacturing Mergers & Acquisitions in the Past Five Years
Table 35. Vaccine Contract Manufacturing New Entrants and Expansion Plans
Table 36. Global Vaccine Contract Manufacturing Revenue (USD Million) by Type (2016-2021)
Table 37. Global Vaccine Contract Manufacturing Revenue Share by Type (2016-2021)
Table 38. Global Vaccine Contract Manufacturing Revenue Forecast by Type (2021-2026)
Table 39. Global Vaccine Contract Manufacturing Revenue by Application (2016-2021)
Table 40. Global Vaccine Contract Manufacturing Revenue Forecast by Application (2021-2026)
Table 41. North America Vaccine Contract Manufacturing Revenue by Type (2016-2021) & (USD Million)
Table 42. North America Vaccine Contract Manufacturing Revenue by Type (2021-2026) & (USD Million)
Table 43. North America Vaccine Contract Manufacturing Revenue by Application (2016-2021) & (USD Million)
Table 44. North America Vaccine Contract Manufacturing Revenue by Application (2021-2026) & (USD Million)
Table 45. North America Vaccine Contract Manufacturing Revenue by Country (2016-2021) & (USD Million)
Table 46. North America Vaccine Contract Manufacturing Revenue by Country (2021-2026) & (USD Million)
Table 47. Europe Vaccine Contract Manufacturing Revenue by Type (2016-2021) & (USD Million)
Table 48. Europe Vaccine Contract Manufacturing Revenue by Type (2021-2026) & (USD Million)
Table 49. Europe Vaccine Contract Manufacturing Revenue by Application (2016-2021) & (USD Million)
Table 50. Europe Vaccine Contract Manufacturing Revenue by Application (2021-2026) & (USD Million)
Table 51. Europe Vaccine Contract Manufacturing Revenue by Country (2016-2021) & (USD Million)
Table 52. Europe Vaccine Contract Manufacturing Revenue by Country (2021-2026) & (USD Million)
Table 53. Asia-Pacific Vaccine Contract Manufacturing Revenue by Type (2016-2021) & (USD Million)
Table 54. Asia-Pacific Vaccine Contract Manufacturing Revenue by Type (2021-2026) & (USD Million)
Table 55. Asia-Pacific Vaccine Contract Manufacturing Revenue by Application (2016-2021) & (USD Million)
Table 56. Asia-Pacific Vaccine Contract Manufacturing Revenue by Application (2021-2026) & (USD Million)
Table 57. Asia-Pacific Vaccine Contract Manufacturing Revenue by Region (2016-2021) & (USD Million)
Table 58. Asia-Pacific Vaccine Contract Manufacturing Revenue by Region (2021-2026) & (USD Million)
Table 59. South America Vaccine Contract Manufacturing Revenue by Type (2016-2021) & (USD Million)
Table 60. South America Vaccine Contract Manufacturing Revenue by Type (2021-2026) & (USD Million)
Table 61. South America Vaccine Contract Manufacturing Revenue by Application (2016-2021) & (USD Million)
Table 62. South America Vaccine Contract Manufacturing Revenue by Application (2021-2026) & (USD Million)
Table 63. South America Vaccine Contract Manufacturing Revenue by Country (2016-2021) & (USD Million)
Table 64. South America Vaccine Contract Manufacturing Revenue by Country (2021-2026) & (USD Million)
Table 65. Middle East & Africa Vaccine Contract Manufacturing Revenue by Type (2016-2021) & (USD Million)
Table 66. Middle East & Africa Vaccine Contract Manufacturing Revenue by Type (2021-2026) & (USD Million)
Table 67. Middle East & Africa Vaccine Contract Manufacturing Revenue by Application (2016-2021) & (USD Million)
Table 68. Middle East & Africa Vaccine Contract Manufacturing Revenue by Application (2021-2026) & (USD Million)
Table 69. Middle East & Africa Vaccine Contract Manufacturing Revenue by Country (2016-2021) & (USD Million)
Table 70. Middle East & Africa Vaccine Contract Manufacturing Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Vaccine Contract Manufacturing Picture
Figure 2. Global Vaccine Contract Manufacturing Revenue Market Share by Type in 2020
Figure 3. Fill-Finish
Figure 4. Bulk Product
Figure 5. Vaccine Contract Manufacturing Revenue Market Share by Application in 2020
Figure 6. Pharmaceutical Companies Picture
Figure 7. Biotech Companies Picture
Figure 8. Others Picture
Figure 9. Global Vaccine Contract Manufacturing Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Vaccine Contract Manufacturing Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Vaccine Contract Manufacturing Revenue Market Share by Region (2016-2026)
Figure 12. Global Vaccine Contract Manufacturing Revenue Market Share by Region in 2020
Figure 13. North America Vaccine Contract Manufacturing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Vaccine Contract Manufacturing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Vaccine Contract Manufacturing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Vaccine Contract Manufacturing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Vaccine Contract Manufacturing Market Drivers
Figure 18. Vaccine Contract Manufacturing Market Restraints
Figure 19. Vaccine Contract Manufacturing Market Trends
Figure 20. Diosynth Recent Developments and Future Plans
Figure 21. Emergent BioSolutions Recent Developments and Future Plans
Figure 22. Goodwin Biotechnology Recent Developments and Future Plans
Figure 23. Bavarian Nordic Recent Developments and Future Plans
Figure 24. Soligenix Inc Recent Developments and Future Plans
Figure 25. Catalent Biologics Recent Developments and Future Plans
Figure 27. Global Vaccine Contract Manufacturing Revenue Share by Players in 2020
Figure 28. Vaccine Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 29. Global Top 3 Players Vaccine Contract Manufacturing Revenue Market Share in 2020
Figure 30. Global Top 10 Players Vaccine Contract Manufacturing Revenue Market Share in 2020
Figure 31. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 32. Global Vaccine Contract Manufacturing Revenue Share by Type in 2020
Figure 33. Global Vaccine Contract Manufacturing Market Share Forecast by Type (2021-2026)
Figure 34. Global Vaccine Contract Manufacturing Revenue Share by Application in 2020
Figure 35. Global Vaccine Contract Manufacturing Market Share Forecast by Application (2021-2026)
Figure 36. North America Vaccine Contract Manufacturing Sales Market Share by Type (2016-2026)
Figure 37. North America Vaccine Contract Manufacturing Sales Market Share by Application (2016-2026)
Figure 38. North America Vaccine Contract Manufacturing Revenue Market Share by Country (2016-2026)
Figure 39. United States Vaccine Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Canada Vaccine Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Mexico Vaccine Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Europe Vaccine Contract Manufacturing Sales Market Share by Type (2016-2026)
Figure 43. Europe Vaccine Contract Manufacturing Sales Market Share by Application (2016-2026)
Figure 44. Europe Vaccine Contract Manufacturing Revenue Market Share by Country (2016-2026)
Figure 45. Germany Vaccine Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. France Vaccine Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. United Kingdom Vaccine Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Russia Vaccine Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Italy Vaccine Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Asia-Pacific Vaccine Contract Manufacturing Sales Market Share by Type (2016-2026)
Figure 51. Asia-Pacific Vaccine Contract Manufacturing Sales Market Share by Application (2016-2026)
Figure 52. Asia-Pacific Vaccine Contract Manufacturing Revenue Market Share by Region (2016-2026)
Figure 53. China Vaccine Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Japan Vaccine Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. South Korea Vaccine Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. India Vaccine Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Southeast Asia Vaccine Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Australia Vaccine Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. South America Vaccine Contract Manufacturing Sales Market Share by Type (2016-2026)
Figure 60. South America Vaccine Contract Manufacturing Sales Market Share by Application (2016-2026)
Figure 61. South America Vaccine Contract Manufacturing Revenue Market Share by Country (2016-2026)
Figure 62. Brazil Vaccine Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Argentina Vaccine Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Middle East and Africa Vaccine Contract Manufacturing Sales Market Share by Type (2016-2026)
Figure 65. Middle East and Africa Vaccine Contract Manufacturing Sales Market Share by Application (2016-2026)
Figure 66. Middle East and Africa Vaccine Contract Manufacturing Revenue Market Share by Country (2016-2026)
Figure 67. Turkey Vaccine Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Saudi Arabia Vaccine Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. UAE Vaccine Contract Manufacturing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Methodology
Figure 71. Research Process and Data Source
世界の製薬契約製造＆契約市場規模・現状・予測（2021年-2027年） Contract pharmaceutical manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing. North America is the largest consumption place, with a consumption mark…- 世界のパーソナルケア契約製造市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Personal Care Contract Manufacturing Market The global Personal Care Contract Manufacturing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and h…
- 世界の整形外科受託製造市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Orthopedic Contract Manufacturing Market The global Orthopedic Contract Manufacturing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high da…
- 世界の包装受託製造市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Packaging Contract Manufacturing Market The global Packaging Contract Manufacturing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data…
- 世界の包装受託製造市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Packaging Contract Manufacturing Market The global Packaging Contract Manufacturing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data…